维普期刊资源整合服务平台（V6.5）

548篇 您的检索式：期刊名="Current Pharmaceutical Design"

选中清除导出查看参考文献查看引证文献引用追踪共28页首页上一页第1页下一页末页 /28 跳转

	题名	作者	年代	出处	被引量
1	Mean Platelet Volume: A Link Between Thrombosis and Inflammation?显示文摘	Armen Yuri Gasparyan Lilit Ayvazyan Dimitri P. Mikhailidis George D. Kitas	2011	Current Pharmaceutical Design2011，，1：	3
2	Helicobacter Pylori and Inflammation显示文摘	Paolo Ruggiero	2010	Current Pharmaceutical Design2010，，38：	3
3	Melatonin, a Promising Supplement in Inflammatory Bowel Disease: A Comprehensive Review of Evidences显示文摘	Shilan Mozaffari Mohammad Abdollahi	2011	Current Pharmaceutical Design2011，，38：	2
4	The Role of Lifestyle Change in the Prevention and Treatment of NAFLD显示文摘	Elena Centis Rebecca Marzocchi Alessandro Suppini Riccardo Dalle Grave Nicola Villanova Ingrid J Hickman Giulio Marchesini	2013	Current Pharmaceutical Design2013，，29：	2
5	From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights显示文摘	Samuele De Minicis Chris Day Gianluca Svegliati-Baroni	2013	Current Pharmaceutical Design2013，，29：	2
6	Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis显示文摘	Albert J. Czaja	2011	Current Pharmaceutical Design2011，，29：	2
7	Epidemiology and Natural History of Patients with NAFLD显示文摘	Neeraj Bhala Ramy Ibrahim Kamal Jouness Elisabetta Bugianesi	2013	Current Pharmaceutical Design2013，，29：	2
8	Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment显示文摘	Paola Dongiovanni Quentin M. Anstee Luca Valenti	2013	Current Pharmaceutical Design2013，，29：	2
9	Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD显示文摘	Amedeo Lonardo Silvia Sookoian Michel Chonchol Paola Loria Giovanni Targher	2013	Current Pharmaceutical Design2013，，29：	2
10	Epigenetic Mechanism Involved in the HBV/HCV-Related Hepatocellular Carcinoma Tumorigenesis显示文摘	Liang Rongrui Huang Na Li Zongfang Ji Fanpu Jiang Shiwen	2014	Current Pharmaceutical Design2014，，11：	2
11	The renin angiotensin system in the regulation of angiogenesis显示文摘	HEFFELF1NGER S C	2007	Current Pharmaceutical Design2007，13，12：	1
12	Wnt/beta-catenin signaling and small molecule inhibitors显示文摘	Andrey V Stefan K	2013	Current Pharmaceutical Design2013，19，：	1
13	Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases显示文摘	Teresa Vanessa Fiorentino Annamaria Prioletta Peng- ou Zuo	2013	Current Pharmaceutical Design2013，19，：	1
14	Mitochondrial Dynamics: An Emerging Paradigm in Ischemia-Reperfusion Injury显示文摘	Lesley Calo Yi Dong Rita Kumar Karin Przyklenk Thomas H. Sanderson	2013	Current Pharmaceutical Design2013，，39：	1
15	Herbal Medicines for the Prevention and Treatment of Alzheimer’s Disease显示文摘	Hyo Geun Kim Myung Sook Oh	2012	Current Pharmaceutical Design2012，，1：	1
16	Genetically engineered bacteriocins and their potential as the next generation of antimierobials显示文摘	GILLOR O NIGRO L M RILEY M A	2005	Current Pharmaceutical Design2005，11，：	1
17	Neurotoxicity of -Amyloid Protein: Oli?gomerization, Channel Formation and Calcium Dyshomeostasis显示文摘	Masahiro Kawahara	2010	Current Pharmaceutical Design2010，16，25：	1
18	Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia显示文摘	Ferraris DV Tsukamoto T	2011	Current Pharmaceutical Design2011，17，2：	1
19	Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer?s Disease-like Phenotype of a Commonly Used Mouse Model显示文摘	Mar Cuadrado-Tejedor Ana L. Ricobaraza Rosana Torrijo Rafael Franco Ana Garcia-Osta	2013	Current Pharmaceutical Design2013，，28：	1
20	Carotenoids and cardiovascular risk显示文摘	Giordano P Scicchitano P Locorotondo M	2012	Current pharmaceutical design2012，18，34：	1

返回顶部每页显示：

共28页首页上一页第1页下一页末页 /28 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示